GLP-1 Startup Kailera Leads Biotech IPO Revival With $625M Deal
Kailera Therapeutics’ $625M GLP-1 IPO anchors a Q2 2026 healthcare listing wave, with Hemab Therapeutics, Avalyn Pharma, and peers all jumping 52-89% from their offer prices.
Stock market news and analysis, with explanations of company developments, earnings and the forces moving share prices. Start with Market Education if you are new to investing. Find your way around ECMSource.
Kailera Therapeutics’ $625M GLP-1 IPO anchors a Q2 2026 healthcare listing wave, with Hemab Therapeutics, Avalyn Pharma, and peers all jumping 52-89% from their offer prices.
AXT Inc. (AXTI) surged 21% after Q1 2026 revenue rose 39% year-over-year to $26.9M, fueled by AI data-center demand for indium phosphide substrates.
Roblox Q1 2026 revenue rose 39% to $1.44B, but widening losses and a guidance cut tied to child safety measures sent shares tumbling 18% on May 1.
Reddit posted $663M in Q1 2026 revenue — up 69% YoY — with ad revenue surging 74% and EPS hitting $1.01. The platform’s AI data edge is real and accelerating.
GameStop is reportedly preparing a bid for eBay. With eBay worth $46B and GME holding $9B in cash, we break down the capital markets math behind Ryan Cohen’s boldest move yet.
Apple beat Q2 2026 estimates with $111.2B revenue (+17% YoY), EPS of $2.01 (+22%), a China upside of $1.6B above consensus, and a new $100B buyback authorization.
Twilio stock climbed nearly 24% after Q1 2026 revenue grew 20% year-over-year to $1.4 billion, with GAAP profitability surging and full-year guidance raised.
WBD shareholders approved Paramount Skydance’s $110B takeover. EU regulators lean yes; FCC weighs foreign ownership stakes in CBS and CNN.
Atlassian stock surged 24% after Q3 FY2026 results crushed estimates — revenue hit $1.79B (+32% YoY), non-GAAP EPS of $1.75 beat by 34%, and Rovo AI credits grew 20%+ monthly.
Merck Q1 2026: $16.3B revenue beat, guidance raised. A $9B acquisition charge drove a GAAP loss, but Winrevair growth signals strong underlying fundamentals.